Table 2.
Sl. No. | Study | Compound(s) | Type of compound | Time of administration | Stroke model(s) | Cell/animal type |
---|---|---|---|---|---|---|
1 | Zaman et al., 1999 | DFO | Iron chelator | Immediately or up to 10 h after HCA∗ treatment | Glutathione depletion model | Rat primary neurons |
Mimosine | Iron chelator | |||||
CoCl2 | Iron competitor | |||||
2 | Siddiq et al., 2005 | DFO | 6 h before MCAO | Glutamate-mediated excitotoxicity/MCAO | Rat primary neurons; Adult male Sprague–Dawley rats | |
DHB | 2OG analog | |||||
Compound A | Iron chelator | |||||
3 | Bergeron et al., 2000 | DFO | 24 h before ligation | Unilateral carotid artery ligation | Male and female Sprague–Dawley rats | |
CoCl2 | ||||||
4 | Prass et al., 2002 | DFO | 48 or 72 h before OGD/MCAO | OGD/MCAO | Rat primary neurons; Male Wistar rats | |
5 | Freret et al., 2006 | DFO | Before and/or shortly after MCAO | MCAO | Sprague–Dawley rats | |
6 | Baranova et al., 2007 | DFO | 6 h before or after MCAO | MCAO | Transgenic C57BL6/J male mice | |
DHB | ||||||
DP | Iron chelator | |||||
7 | Siddiq et al., 2009 | DFO | Before or along with HCA | Glutathione depletion model | HT22 murine hippocampal cells | |
DHB | ||||||
DMOG | 2OG analog | |||||
8 | Hamrick et al., 2005 | DFO | 1 h before and during OGD | OGD | Hippocampal cells | |
9 | Mu et al., 2005 | DFO | Immediately after MCAO | MCAO | Female Sprague–Dawley rats | |
10 | Hanson et al., 2009 | DFO | Multiple times before or after MCAO | MCAO | Male Sprague–Dawley rats | |
11 | Zhao and Rempe, 2011 | DFO | Every day up to 4 weeks before MCAO | MCAO | Mice | |
DFR | Iron chelator | |||||
12 | Jones and Bergeron, 2001 | CoCl2 | 24 h before MCAO | MCAO | Male and female Sprague–Dawley rats | |
13 | Demougeot et al., 2004 | DP | Iron chelator | 15 min before and 1 h after occlusion | Cortical photothrombotic vascular occlusion | Adult male Wistar rats |
14 | Hoecke et al., 2005 | DP | 15 min before and 1 h after occlusion | Cortical photothrombotic vascular occlusion | Adult male Wistar rats | |
15 | Ogle et al., 2012 | DMOG | 24 h before OGD and 2 h after initiation of OGD; 30 or 60 min after reperfusion | OGD/MCAO | Primary neurons; Adult male B6129PF2/J mice | |
16 | Nagel et al., 2011 | DMOG | Multiple times before and one time after MCAO | Permanent or transient MCAO | Adult male Wistar rats | |
17 | Reischl et al., 2014 | FG-4497 | Not specified | 6, 24, and 48 h during OGD; 6 h before or soon after MCAO | MCAO | Primary murine astrocytes and HT-22 hippocampal neuronal cells; Male C57BL/6 mice |
18 | Chen et al., 2014 | IOX3 | Not specified | One day or immediately before MCAO | MCAO | Male C57/B6 mice |
19 | Zhou et al., 2017 | GSK360A | Not specified | 18 and 5 h before MCAO | MCAO | Male Sprague–Dawley rats |
20 | Kontani et al., 2013 | TM6008 | Not specified | Immediately after hypoxia | Anaerobic chamber | SHSY-5Y cells |
21 | Zhang Q. et al., 2014 | HLJDT | Unknown | 24 h before OGD or MCAO | OGD; MCAO | Rat primary neurons; Male Sprague–Dawley rats |
∗HCA, homocysteic acid.